Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: Randomised, double-blind, placebo-controlled, crossover trial (Lancet (2009) 373 (633-640))

A. Gottlieb, A. Menter, A. Mendelsohn

Research output: Contribution to journalComment/debate

2 Scopus citations
Original languageEnglish
Pages (from-to)1542
Number of pages1
JournalThe Lancet
Volume376
Issue number9752
DOIs
StatePublished - 6 Nov 2010

Cite this